Genpact Limited (NYSE:G) Receives Consensus Rating of “Hold” from Brokerages

Genpact Limited (NYSE:GGet Free Report) has been assigned a consensus rating of “Hold” from the nine brokerages that are currently covering the stock, Marketbeat Ratings reports. Six research analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $48.44.

A number of analysts recently issued reports on the company. Jefferies Financial Group upgraded Genpact from a “hold” rating to a “buy” rating and boosted their price objective for the company from $44.00 to $55.00 in a research note on Tuesday, January 21st. Mizuho boosted their price objective on Genpact from $45.00 to $55.00 and gave the company a “neutral” rating in a research note on Monday, February 10th. TD Cowen upgraded Genpact from a “hold” rating to a “buy” rating and boosted their price objective for the company from $45.00 to $60.00 in a research note on Friday, February 7th. Needham & Company LLC boosted their price objective on Genpact from $55.00 to $65.00 and gave the company a “buy” rating in a research note on Friday, February 7th. Finally, Robert W. Baird boosted their target price on Genpact from $44.00 to $48.00 and gave the stock a “neutral” rating in a research report on Friday, November 8th.

Check Out Our Latest Report on G

Insider Buying and Selling

In other Genpact news, SVP Piyush Mehta sold 12,000 shares of the firm’s stock in a transaction dated Friday, January 10th. The stock was sold at an average price of $42.83, for a total transaction of $513,960.00. Following the sale, the senior vice president now directly owns 151,182 shares of the company’s stock, valued at $6,475,125.06. This trade represents a 7.35 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Balkrishan Kalra sold 13,600 shares of the firm’s stock in a transaction dated Friday, December 13th. The shares were sold at an average price of $44.60, for a total value of $606,560.00. Following the sale, the chief executive officer now directly owns 267,404 shares in the company, valued at approximately $11,926,218.40. This represents a 4.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.80% of the stock is owned by insiders.

Institutional Investors Weigh In On Genpact

Several large investors have recently made changes to their positions in the company. Coppell Advisory Solutions LLC boosted its position in shares of Genpact by 529.5% during the fourth quarter. Coppell Advisory Solutions LLC now owns 598 shares of the business services provider’s stock valued at $25,000 after buying an additional 503 shares during the period. SRH Advisors LLC purchased a new position in shares of Genpact during the fourth quarter valued at approximately $26,000. Atlas Capital Advisors Inc. boosted its position in shares of Genpact by 55.8% during the fourth quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider’s stock valued at $26,000 after buying an additional 216 shares during the period. Manchester Capital Management LLC purchased a new position in shares of Genpact during the fourth quarter valued at approximately $38,000. Finally, GeoWealth Management LLC boosted its position in shares of Genpact by 199.0% during the fourth quarter. GeoWealth Management LLC now owns 876 shares of the business services provider’s stock valued at $38,000 after buying an additional 583 shares during the period. 96.03% of the stock is owned by institutional investors.

Genpact Stock Performance

Shares of Genpact stock opened at $52.50 on Wednesday. The business’s fifty day simple moving average is $47.36 and its 200 day simple moving average is $43.13. The firm has a market capitalization of $9.26 billion, a P/E ratio of 18.48, a price-to-earnings-growth ratio of 1.84 and a beta of 1.20. Genpact has a 12 month low of $30.23 and a 12 month high of $56.76. The company has a current ratio of 2.16, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50.

Genpact (NYSE:GGet Free Report) last issued its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.82 EPS for the quarter, missing analysts’ consensus estimates of $0.86 by ($0.04). Genpact had a return on equity of 22.50% and a net margin of 10.77%. As a group, analysts anticipate that Genpact will post 3.21 EPS for the current year.

Genpact Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Tuesday, March 11th will be paid a $0.17 dividend. This is an increase from Genpact’s previous quarterly dividend of $0.15. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.30%. The ex-dividend date of this dividend is Tuesday, March 11th. Genpact’s dividend payout ratio (DPR) is 23.94%.

Genpact Company Profile

(Get Free Report

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Featured Stories

Analyst Recommendations for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.